Wordt geladen...
Acquisition of Paclitaxel Resistance Is Associated With a More Aggressive and Invasive Phenotype in Prostate Cancer
Drug resistance is a major limitation to the successful treatment of advanced prostate cancer (PCa). Patients who have metastatic, castration-resistant PCa (mCRPC) are treated with chemotherapeutics. However, these standard therapy modalities culminate in the development of resistance. We establishe...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4211414/ https://ncbi.nlm.nih.gov/pubmed/23192682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcb.24464 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|